EUVIMEDEUVIMED entdecken
Multizentrische Studie

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

David Marti-Aguado iD, Joud Arnouk, Jia-Xu Liang, Carmen Lara-Romero, Jaideep Behari, Alessandro Furlan, Ana Jimenez-Pastor, Amadeo Ten-Esteve, Clara Alfaro-Cervello, Mónica Bauza, Ana Gallen-Peris, Marta Gimeno-Torres und 16 weitere

Liver International · 2024-01 · 44 (1) · 202-213

DOI: 10.1111/liv.15766 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 30.10.2023. Verfasst von David Marti-Aguado und 27 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Gilead Sciences, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Diagnosis of metabolic dysfunction‐associated steatohepatitis (MASH) requires histology. In this study, a magnetic resonance imaging (MRI) score was developed and validated to identify MASH in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). Secondarily, a screening strategy for MASH diagnosis was investigated.

Methods

This prospective multicentre study included 317 patients with biopsy‐proven MASLD and contemporaneous MRI. The discovery cohort (Spain, Portugal) included 194 patients. NAFLD activity score (NAS) and fibrosis were assessed with the NASH‐CRN histologic system. MASH was defined by the presence of steatosis, lobular inflammation, and ballooning, with NAS ≥4 with or without fibrosis. An MRI‐based composite biomarker of Proton Density Fat Fraction and waist circumference (MR–MASH score) was developed. Findings were afterwards validated in an independent cohort (United States, Spain) with different MRI protocols.

Results

In the derivation cohort, 51% ( n = 99) had MASH. The MR–MASH score identified MASH with an AUC = .88 (95% CI .83–.93) and strongly correlated with NAS ( r = .69). The MRI score lower cut‐off corresponded to 88% sensitivity with 86% NPV, while the upper cut‐off corresponded to 92% specificity with 87% PPV. MR–MASH was validated with an AUC = .86 (95% CI .77–.92), 91% sensitivity (lower cut‐off) and 87% specificity (upper cut‐off). A two‐step screening strategy with sequential MR–MASH examination performed in patients with indeterminate‐high FIB‐4 or transient elastography showed an 83–84% PPV to identify MASH. The AUC of MR–MASH was significantly higher than that of the FAST score ( p < .001).

Conclusions

The MR–MASH score has clinical utility in the identification and management of patients with MASH at risk of progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverNon-alcoholic Fatty Liver DiseaseHumansProspective StudiesMagnetic Resonance ImagingFibrosisBiopsyBiomarkersLiver Cirrhosis

Stichwörter der Autor:innen

magnetic resonancemetabolic dysfunction-associated steatohepatitisproton density fat fractionwaist circumference

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Digestive Disease Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Biomedical Imaging Research Group (GIBI230), La Fe Health Research Institute, and Imaging La Fe node at Distributed Network for Biomedical Imaging (ReDIB) Unique Scientific and Technical Infrastructures (ICTS), Valencia…
  • Division of Gastroenterology, Hepatology and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Digestive Diseases Department, CIBERehd, Virgen del Rocio University Hospital, Seville, Spain.
  • Institute of Biomedicine of Seville (HUVR/CSIC/US), Department of Medicine, University of Seville, Seville, Spain.
  • Division of Abdominal Imaging, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: David Marti-Aguado, Alexandre Perez-Girbes, Salvador Benlloch, Manuel Romero-Gomez

Förderung

  • Gilead Sciences
  • Instituto de Salud Carlos III

Zitieren

APA

Marti-Aguado, D., Arnouk, J., Liang, J. X., Lara-Romero, C., Behari, J., Furlan, A., Jimenez-Pastor, A., Ten-Esteve, A., Alfaro-Cervello, C., Bauza, M., Gallen-Peris, A., Gimeno-Torres, M., Merino-Murgui, V., Perez-Girbes, A., Benlloch, S., Pérez-Rojas, J., Puglia, V., Ferrández-Izquierdo, A., Aguilera, V., …, & Marti-Bonmati, L. (2024). Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score. Liver International, 44(1), 202-213. https://doi.org/10.1111/liv.15766

Vancouver

Marti-Aguado D, Arnouk J, Liang JX, Lara-Romero C, Behari J, Furlan A, et al. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score. Liver International. 2024;44(1):202-213. doi:10.1111/liv.15766

BibTeX
@article{MartiAguado2024,
  author = {Marti-Aguado, David and Arnouk, Joud and Liang, Jia-Xu and Lara-Romero, Carmen and Behari, Jaideep and Furlan, Alessandro and Jimenez-Pastor, Ana and Ten-Esteve, Amadeo and Alfaro-Cervello, Clara and Bauza, Mónica and Gallen-Peris, Ana and Gimeno-Torres, Marta and Merino-Murgui, Víctor and Perez-Girbes, Alexandre and Benlloch, Salvador and Pérez-Rojas, Judith and Puglia, Víctor and Ferrández-Izquierdo, Antonio and Aguilera, Victoria and Giesteira, Bruno and França, Manuela and Monton, Cristina and Escudero-García, Desamparados and Alberich-Bayarri, Ángel and Serra, Miguel A and Bataller, Ramon and Romero-Gomez, Manuel and Marti-Bonmati, Luis},
  title = {Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {1},
  pages = {202--213},
  doi = {10.1111/liv.15766}
}
Kostenlos starten →